PD-L1 testing: comparing analytic sensitivity among FDA-cleared and LDT assays

PD-L1 testing: comparing analytic sensitivity among FDA-cleared and LDT assays

Collaborator(s): Canadian Biomarker Quality Assurance (CBQA) organization and laboratories in the Netherlands, Belgium, and the U.S.

Status: Completed

Abstract: [Link]

Poster: [Link]

Peer-Reviewed Journal: Pending